ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Lipocine Inc

Lipocine Inc (LPCN)

7.18
-3.51
(-32.83%)
Closed June 19 4:00PM
7.60
0.42
(5.85%)
After Hours: 7:13PM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
7.60
Bid
7.16
Ask
7.60
Volume
446,337
6.27 Day's Range 11.79
2.3101 52 Week Range 11.79
Market Cap
Previous Close
10.69
Open
11.01
Last Trade
60
@
7.16
Last Trade Time
Financial Volume
$ 3,993,930
VWAP
8.9482
Average Volume (3m)
78,358
Shares Outstanding
5,315,830
Dividend Yield
-
PE Ratio
-2.33
Earnings Per Share (EPS)
-3.08
Revenue
-2.85M
Net Profit
-16.35M

About Lipocine Inc

Lipocine Inc is a clinical-stage biopharmaceutical company. It is focused on oral drug delivery technology for the development of pharmaceutical products focusing on metabolic and endocrine disorders. The company product TLANDO is an oral testosterone replacement therapy TRT. It also has other produ... Lipocine Inc is a clinical-stage biopharmaceutical company. It is focused on oral drug delivery technology for the development of pharmaceutical products focusing on metabolic and endocrine disorders. The company product TLANDO is an oral testosterone replacement therapy TRT. It also has other products in the pipeline such as LPCN 1144 LPCN 1148 and LPCN 1107. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
1970
Lipocine Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker LPCN. The last closing price for Lipocine was $10.69. Over the last year, Lipocine shares have traded in a share price range of $ 2.3101 to $ 11.79.

Lipocine currently has 5,315,830 shares outstanding. The market capitalization of Lipocine is $38.11 million. Lipocine has a price to earnings ratio (PE ratio) of -2.33.

LPCN Latest News

Lipocine Presents 52 Week Results from LPCN 1148 Phase 2 Study in Late Breaking Session at EASL Congress 2024

Lipocine Presents 52 Week Results from LPCN 1148 Phase 2 Study in Late Breaking Session at EASL Congress 2024 PR Newswire SALT LAKE CITY, June 10, 2024 SALT LAKE CITY, June 10, 2024 /PRNewswire/...

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CMTLComtech Telecommunications Corporation
$ 4.07
(87.56%)
91.43M
NLSPNLS Pharmaceutics Ltd
$ 0.2735
(84.42%)
305.35M
ASNSActelis Networks Inc
$ 2.11
(83.48%)
51.37M
RELIReliance Global Group Inc
$ 0.40
(80.18%)
394.85M
LRHCLa Rosa Holdings Corporation
$ 1.78
(71.15%)
52.9M
STISolidion Technology Inc
$ 0.6881
(-64.35%)
16.36M
DMTKDermTech Inc
$ 0.1488
(-55.25%)
10.74M
QMCOQuantum Corporation
$ 0.3752
(-51.90%)
3.14M
ZNTLZentalis Pharmaceuticals Inc
$ 4.135
(-50.72%)
21.58M
AWINAERWINS Technologies Inc
$ 1.74
(-47.90%)
1.05M
RELIReliance Global Group Inc
$ 0.40
(80.18%)
394.85M
NLSPNLS Pharmaceutics Ltd
$ 0.2735
(84.42%)
305.35M
NVDANVIDIA Corporation
$ 135.58
(3.51%)
294.32M
MBIOMustang Bio Inc
$ 0.8517
(13.56%)
291.95M
CRKNCrown Electrokinetics Corporation
$ 0.0548
(-17.10%)
92.39M

LPCN Discussion

View Posts
Monksdream Monksdream 2 months ago
LPCN under $10
๐Ÿ‘๏ธ0
Awl416 Awl416 2 months ago
Lipocine Announces Positive LPCN 2401 Clinical Results Showing Improved Body Composition in Participants with Obesity
๐Ÿ‘๏ธ0
Monksdream Monksdream 3 months ago
LPCN under $10
๐Ÿ‘๏ธ0
Monksdream Monksdream 5 months ago
Early Barchart 100
https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc
๐Ÿ‘๏ธ0
Monksdream Monksdream 11 months ago
Early Barchart Top 100
https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc
๐Ÿ‘๏ธ0
Triple nickle Triple nickle 1 year ago
Bottom was in on the eighth
๐Ÿ‘๏ธ0
Triple nickle Triple nickle 1 year ago
Added
๐Ÿ‘๏ธ0
LQMTinvestor2018 LQMTinvestor2018 2 years ago
Clueless
๐Ÿ‘๏ธ0
gi197845 gi197845 2 years ago
Forward split then, lol. Shelf offering! Dilution!
๐Ÿ‘๏ธ0
LQMTinvestor2018 LQMTinvestor2018 2 years ago
Yes but that is the exact opposite of a reverse split which is what you said. Reverse splits lower share countโ€ฆ.
๐Ÿ‘๏ธ0
gi197845 gi197845 2 years ago
Increasing authorized shares can have the same end result as a split, meaning each share can be worth less, due to more shares.
๐Ÿ‘๏ธ0
LQMTinvestor2018 LQMTinvestor2018 2 years ago
Increasing authorized shares is not a reverse split โ€ฆ.
๐Ÿ‘๏ธ0
LQMTinvestor2018 LQMTinvestor2018 2 years ago
There is no reverse split vote!
๐Ÿ‘๏ธ0
gi197845 gi197845 2 years ago
Yes, I'm voting to reverse split.
๐Ÿ‘๏ธ0
LQMTinvestor2018 LQMTinvestor2018 2 years ago
There is no reverse split vote โ€ฆ.
๐Ÿ‘๏ธ0
gi197845 gi197845 2 years ago
Dilution, reverse split, recession and bankruptcy.

DRSRB!
๐Ÿ‘๏ธ0
gi197845 gi197845 2 years ago
Well, with the upcoming reverse split vote, if approved, leads to dilution, thereby pushing the stock price down.
๐Ÿ‘๏ธ0
BesaoT35 BesaoT35 2 years ago
I am amazed that LPCN is now 0.92. Testosterone replacement therapy is a large market. Will sales disappoint for a reason?
๐Ÿ‘๏ธ0
Pyramid2 Pyramid2 2 years ago
"I" am always amazed when a small cap BIO gets approval for their testosterone pill over a Big Pharma that stole it and gets nailed to cross makes their stock sink?, "I" guess girls with Testosterone and Males with LPCN so no MALES in this market/world? On Watch for some males...
๐Ÿ‘๏ธ0
gi197845 gi197845 2 years ago
This LPCN message board ROCKS!!!
๐Ÿ‘๏ธ0
RunninRobert RunninRobert 2 years ago


In my last summary (Jan2022) the stock was under a dollar and now its looking strong, I am very bullish going forward with it. Not alot of downside ATM
๐Ÿ‘๏ธ0
MF2 MF2 2 years ago
28 of march TLANDO pdufa, 10th march financials, this stock may grow until the approval date and over.
๐Ÿ‘๏ธ0
MF2 MF2 2 years ago
28 march pdufa for TLANDO and 10th sec filling am I wrong? I think this stock is going to grow constantly until 28th of march and over.
๐Ÿ‘๏ธ0
gi197845 gi197845 2 years ago
Something, nothing, anything, everything!
๐Ÿ‘๏ธ0
everyonesguess everyonesguess 2 years ago
You said ever thing and nothing. Perfect job done.
๐Ÿ‘๏ธ0
gi197845 gi197845 3 years ago
Yes, you are correct, in March 2022, Tlando can be marketed to the public.
๐Ÿ‘๏ธ0
BesaoT35 BesaoT35 3 years ago
I remember that March 2022 is when the exclusivity for Clarus was going to end and that we could then sell our oral testosterone pills called Tlando. That was a provisional FDA decision. Is this still the case?
Thanks
๐Ÿ‘๏ธ0
gi197845 gi197845 3 years ago
Shart!!!
๐Ÿ‘๏ธ0
BesaoT35 BesaoT35 3 years ago
If the news was good with the NASH data why is the stock flat to down?
๐Ÿ‘๏ธ0
gi197845 gi197845 3 years ago
Well the NASH news is out and the results are good.
๐Ÿ‘๏ธ0
LQMTinvestor2018 LQMTinvestor2018 3 years ago
Any time this month
๐Ÿ‘๏ธ0
BesaoT35 BesaoT35 3 years ago
When are we expecting NASH data? Thanks.
๐Ÿ‘๏ธ0
gi197845 gi197845 3 years ago
Someday this stock price will either go up or go down. I'm so glad I could help.
๐Ÿ‘๏ธ0
gi197845 gi197845 3 years ago
It's going to be a win win.
๐Ÿ‘๏ธ0
gi197845 gi197845 3 years ago
Do'h!
๐Ÿ‘๏ธ0
Vance Vance 3 years ago
Actually things look pretty darn good! Lawsuit aside, our pipeline is intact & progressing. TLando will still gain full approval next March, partnership news imminent (possibly soon after A/S increase),
1144 results due in a couple months with no bad expectations... yeah I'd say things are looking pretty good!
๐Ÿ‘๏ธ0
gi197845 gi197845 3 years ago
Yes, things don't look good for Lipocine or its' investors.
๐Ÿ‘๏ธ0
Rapier1911 Rapier1911 3 years ago
https://ih.advfn.com/stock-market/NASDAQ/lipocine-LPCN/stock-news/85206412/clarus-therapeutics-defeats-lipocines-patent-infri
๐Ÿ‘๏ธ0
gi197845 gi197845 3 years ago
Quite the range today, 1.25 to 1.56.
๐Ÿ‘๏ธ0
gi197845 gi197845 3 years ago
Correction, huge volume today.
๐Ÿ‘๏ธ0
gi197845 gi197845 3 years ago
Wow, big volume today.
๐Ÿ‘๏ธ0
Vance Vance 3 years ago
Not yet
๐Ÿ‘๏ธ0
BesaoT35 BesaoT35 3 years ago
Is there a date for the Clarus court case?
๐Ÿ‘๏ธ0
gi197845 gi197845 3 years ago
Do'h @ 1.38 now...
How low can she go?
She be going down~!
๐Ÿ‘๏ธ0
Vance Vance 3 years ago
Are you still long on LPCN?
I Am Long.

How long have you been in LPCN?
I Came Across Lipocine in August of last year.

Do you care to share your average pps or number of shares?
I have bought and sold my holdings several times to place other trades, ultimately resulting in an increase in current shares held.

It appears that Lipocine has not interest in suing in court. What's the court status?
Court status is apparent, awaiting trial scheduling. Lipocine brought the suit against Clarus to sue in court.

I don't think Lipocine is going to get a favorable deal for marketing Tlando. Am I being too negative? When will we hear about a partnership?
It is my opinion the litigation against Clarus and/or Phase 2 1144 results would need to wrap up before a partnering announcement. However, talks are obviously ongoing per an overly excited birdy named Patel. TLando is a money maker, any partner will know that!



It is anybodys guess as to when a good catalyst will hit; analyst upgrade, pipeline news, partnership, trial, nash results, etc.. so my mention of selling to run trades is risky. But, I've been lucky with timing and I Only jump ship on damn good prospects of a daytrade or overnight hold. Long and short alike. You might try paper trading your position (no risk) to see how you do with that, then jump in sometime if you feel confident. No risk, no reward!

As for Long term vs under 12 month holds, taxes are not my concern. Profit is, and if I turn a buck into two and have to pay forty cents, I'm still sixty cents up!

G'luk

๐Ÿ‘๏ธ0
gi197845 gi197845 3 years ago
I wonder what the results of the court case are and when it will reported? Meanwhile the share price is going down, down, down, to the burning ring of fire...
๐Ÿ‘๏ธ0
gi197845 gi197845 3 years ago
It's a pretty substantial drop from 1.47 to 1.37 today. We'll see what the future holds for this.
๐Ÿ‘๏ธ0
gi197845 gi197845 3 years ago
Thanks Vance, thus far I think it's been proven that an r/s is not up for a vote, it's the dilution that's up for a vote.

Are you still long on LPCN?
How long have you been in LPCN?
Do you care to share your average pps or number of shares?

I'm not trying to be negative here, but here are some of my thoughts...

It's a shame that Tlando only got tentative approval, for marketing in March 2022, due to the fraudulent exclusivity of Jatenzo.

It appears that Lipocine has not interest in suing in court. What's the court status?

It appears that no one would want a 2 or 3 times per day Tlando pill, when Xtlando, with a once per day dose would be preferred.

It appears that no one, the FDA, patients, or big pharma has much if any interest in a T-booster pill.

I don't think Lipocine is going to get a favorable deal for marketing Tlando. Am I being too negative? When will we hear about a partnership?

Positive Nash results will be a bigger deal than Tlando, or at least a good catalyst. Unfortunately, I guess it wasn't tested on alcoholics livers, but if it treats fatty livers good, maybe it could be prescribed off label to alcoholics...

As of writing this, I'm not under water. I'm considering to bale out in full now and if I do that, I'm considering getting back in, in early 2023.

Also, the Biden Admin wants price controls/socialized medicine, which might even happen with another executive order, so lower profits for big pharma, hedge funds and us retail investors. As well as lower research capital for new drugs...

Drug costs can't just be fixed with price controls, they also need to lower NDA and SNDA costs with the FDA as well as somehow reduce the cost of drug trials.

I was under water for a,ong time on, LPCN after the FDA first reject Tlando, so I bought more and up above water now, but I mostly just see cash burning and delays here.

In the extremely long run LPCN could be a win, but if I stay in I think I'll go undwer water as the stock price tanks for the next year or so...

Am I'm being too negative and paranoid or am I being realistic. What are your thoughts?

Thank you.
๐Ÿ‘๏ธ0
Vance Vance 3 years ago
You really ought to sell any shares you have in Lipocine if you believe there is any truth to your assessment.
๐Ÿ‘๏ธ0
gi197845 gi197845 3 years ago
Before or after the r/s and dilution?
๐Ÿ‘๏ธ0